ArticleAnnals of medicine and surgery (2012)2025
Hashimoto's encephalopathy: a rare case report of Hashimoto's thyroiditis with seizure.
Article in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction and importance: Hashimoto's thyroiditis (HT) is a common autoimmune condition that causes hypothyroidism. It is characterized by a wide range of symptoms, from conventional ones to rare and severe neurological manifestations. Seizures are a very uncommon symptom of HT, requiring a deep understanding and careful management owing to the challenges involved in diagnosing and the severe implications. Case presentation: A 19-year-old female with a medical history of untreated hypothyroidism caused by HT presented with a seizure characterized by generalized tonic-clonic movements. She displayed symptoms of fatigue, confusion, and swelling in the extremities. The laboratory results indicated a significant case of autoimmune hypothyroidism. The results of the brain imaging and EEG tests were within the expected range and did not show any abnormalities. The treatment regimen consisted of levothyroxine, levetiracetam, and methyl-prednisolone, which led to the cessation of seizures and the patient's recovery from the postictal state. Clinical discussion: While managing HT itself is well-defined, tackling the neurologic complexities of Hashimoto's encephalopathy (HE) takes a multifaceted approach. Conclusion: This case highlights the intricate nature of diagnosing and managing neurological symptoms caused by HT, namely seizures. Patients presenting with unexplained seizures and autoimmune thyroid illness should be mindful of the possibility of HE, an uncommon condition. Management includes the attainment of normal thyroid function and the consideration of immunosuppressive therapy for severe instances of HE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.